Rubin Jonathan 4
4 · SUPERNUS PHARMACEUTICALS, INC. · Filed Sep 12, 2025
Insider Transaction Report
Form 4
Rubin Jonathan
SVP, Chief Medical Officer
Transactions
- Award
Performance Share Unit
2025-09-10+1,875→ 1,875 totalExercise: $0.00→ Common Stock (1,875 underlying)
Holdings
- 9,980
Common Stock
Footnotes (2)
- [F1]Includes an aggregate of 345 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan.
- [F2]On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024.